Literature DB >> 17191853

Eudesmane derivatives from Hieracium intybaceum.

Sandra Grass1, Christian Zidorn, Ernst P Ellmerer, Hermann Stuppner.   

Abstract

Two new eudesmanolides, 4beta-H,3beta-(beta-D-glucopyranosyloxy)eudesma-1,11(13)-dien-12,6-olide (5a) and 3beta-D-glucopyranosyloxyeudesma-1,4(15),11(13)-trien-12,6-olide (5b), as well as two related, known compounds, tuberiferin (7a) and dehydrobrachylaenolide (7b), were isolated from the CH2Cl2 extract of subaerial parts of Hieracium intybaceum All. Compounds 6a, 6b, 8a, and 8b, the Me esters of the corresponding sesquiterpenic acids related to 5a, 5b, 7a, and 7b, respectively, were obtained as artifacts during the isolation process. Additionally, linoleic acid (1), linolenic acid (2), the lignane syringaresinol 4'-O-beta-D-glucopyranoside (3), and the guaianolide dehydrocostus lactone (4) were also isolated from H. intybaceum. Structure elucidations were based on mass spectrometry and extensive 1D- and 2D-NMR spectroscopy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 17191853     DOI: 10.1002/cbdv.200490031

Source DB:  PubMed          Journal:  Chem Biodivers        ISSN: 1612-1872            Impact factor:   2.408


  3 in total

1.  Furofuran lignans from a callus culture of Cichorium intybus.

Authors:  J Malarz; A Stojakowska; E Szneler; W Kisiel
Journal:  Plant Cell Rep       Date:  2005-04-05       Impact factor: 4.570

2.  Dehydro-brachylaenolide: an eudesmane-type sesquiterpene lactone.

Authors:  M Rademeyer; F R van Heerden; M M van der Merwe
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-12-24

3.  In vitro anti-plasmodial activity of Dicoma anomala subsp. gerrardii (Asteraceae): identification of its main active constituent, structure-activity relationship studies and gene expression profiling.

Authors:  John V W Becker; Marina M van der Merwe; Anna C van Brummelen; Pamisha Pillay; Bridget G Crampton; Edwin M Mmutlane; Chris Parkinson; Fanie R van Heerden; Neil R Crouch; Peter J Smith; Dalu T Mancama; Vinesh J Maharaj
Journal:  Malar J       Date:  2011-10-11       Impact factor: 2.979

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.